Average Co-Inventor Count = 4.85
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Eisai R&d Management Co., Ltd. (20 from 530 patents)
2. Otsuka Pharmaceutical Company, Limited (3 from 846 patents)
3. Epizyme, Inc. (1 from 158 patents)
23 patents:
1. 12251394 - Methods for the treatment of bladder cancer
2. 11643418 - Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin B
3. 11542269 - Prins reaction and compounds useful in the synthesis of halichondrin macrolides and analogs thereof
4. 11434246 - EP4 antagonists
5. 11339188 - Compounds for the treatment of cancer
6. 11136335 - Prins reaction and intermediates useful in the synthesis of halichondrin macrolides and analogs thereof
7. 11028119 - Synthetic route to 2'-deoxy-2′,2′-difluorotetrahydrouridines
8. 10941148 - EP4 antagonists
9. 10934307 - Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin B
10. 10913749 - Macrocyclization reactions and intermediates and other fragments useful in the synthesis of halichondrin macrolides
11. 10793581 - Stereochemically defined polypropionates and methods for making and using the same
12. 10618930 - Compounds for the treatment of cancer
13. 10611773 - Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin B
14. 10526362 - Synthetic route to 2'-deoxy-2′,2′-difluorotetrahydrouridines
15. 10407439 - Stereochemically defined polypropionates and methods for making and using the same